The South & Central America parenteral nutrition market was valued at US$ 360.63 million in 2022 and is expected to reach US$ 597.42 million by 2030; it is estimated to record a CAGR of 6.5% from 2022 to 2030.
Improved Healthcare Infrastructure Fuels South & Central America Parenteral Nutrition Market
With over 19,000 hospitals in the region, Latin America provides a wide range of healthcare options. As of 2023, there will be 6,642 more hospitals in Brazil than there are in the US. Investments in healthcare infrastructure and the expansion of healthcare facilities in the South & Central America region present opportunities for the development and distribution of parenteral nutrition products and services.
Additionally, malnutrition affects 74% of severely ill hospitalized patients in Latin America. In order to fight patient malnutrition in Latin America and around the world, Fresenius Kabi is dedicated to advancing research and providing funds. Under the 'United for Clinical Nutrition' project, which aims to strengthen clinical research in Latin America, the company has provided research grants totaling US$ 106,630 (100,000) since 2018.
In 2023, Healthcare practitioners applied for the third Parenteral Nutrition Research Grant Latin America to fund clinical nutrition research initiatives. The award is valid for two years. It seeks to support serious research in parenteral nutrition therapy, help solve the problem of malnourished critically ill patients in Latin America and provide funds to support additional research that will support appropriate parenteral nutrition.
South & Central America Parenteral Nutrition Market Overview
The incidence of neurological disorders has been correlated with the aging population in Brazil. According to the World Health Organization and the Brazilian Institute of Geography and Statistics, by 2040, the geriatric population in Brazil (aged above 60 years) will reach ~55 million. In the coming years, the rising geriatric population is anticipated to increase the incidence of chronic neurological disorders, which is likely to propel the demand for parenteral nutrition. Thus, the growing incidence of diabetes, cancer, and other chronic diseases drives the parenteral nutrition market in Brazil. This factor is likely to increase the demand for parenteral nutrition in treating patients.
South & Central America Parenteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Parenteral Nutrition Market Segmentation
The South & Central America parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the South & Central America parenteral nutrition market is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held the largest market share in 2022.
By end user, the South & Central America parenteral nutrition market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.
Based on country, the South & Central America parenteral nutrition market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America parenteral nutrition market share in 2022.
ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, and Vifor Pharma Management AG are some of the leading players operating in the South & Central America parenteral nutrition market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 360.63 Million |
| Market Size by 2030 | US$ 597.42 Million |
| CAGR (2022 - 2030) | 6.5% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By Nutrient Type
|
|
Regions and Countries Covered
|
|
| South and Central America | Brazil, Argentina, Rest of South and Central America |
| Market leaders and key company profiles |
|
1. ICU Medical Inc
2. Grifols SA
3. Pfizer Inc
4. Otsuka Pharmaceuticals Co Ltd
5. Baxter International Inc
6. B Braun SE
7. Fresenius Kabi AG
8. Aculife Healthcare Pvt Ltd
9. Vifor Pharma Management AG
The South & Central America Parenteral Nutrition Market is valued at US$ 360.63 Million in 2022, it is projected to reach US$ 597.42 Million by 2030.
As per our report South & Central America Parenteral Nutrition Market, the market size is valued at US$ 360.63 Million in 2022, projecting it to reach US$ 597.42 Million by 2030. This translates to a CAGR of approximately 6.5% during the forecast period.
The South & Central America Parenteral Nutrition Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Parenteral Nutrition Market report:
The South & Central America Parenteral Nutrition Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Parenteral Nutrition Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Parenteral Nutrition Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For South & Central America Parenteral Nutrition Market
